L-Isoleucine reverses hyperammonemia-induced myotube mitochondrial dysfunction and post-mitotic senescence

J Nutr Biochem. 2024 Jan:123:109498. doi: 10.1016/j.jnutbio.2023.109498. Epub 2023 Oct 21.

Abstract

Perturbations in the metabolism of ammonia, a cytotoxic endogenous metabolite, occur in a number of chronic diseases, with consequent hyperammonemia. Increased skeletal muscle ammonia uptake causes metabolic, molecular, and phenotype alterations including cataplerosis of (loss of tricarboxylic acid cycle (TCA) cycle intermediate) α-ketoglutarate (αKG), mitochondrial oxidative dysfunction, and senescence-associated molecular phenotype (SAMP). L-Isoleucine (Ile) is an essential, branched-chain amino acid (BCAA) that simultaneously provides acetyl-CoA as an oxidative substrate and succinyl-CoA for anaplerosis (providing TCA cycle intermediates). Our multiomics analyses in myotubes and skeletal muscle from hyperammonemic mice and human patients with cirrhosis showed perturbations in BCAA transporters and catabolism. We, therefore, determined if Ile reverses hyperammonemia-induced impaired mitochondrial oxidative function and SAMP. Studies were performed in differentiated murine C2C12 myotubes that were early passage, late passage (senescent), or those depleted of LAT1/SLC7A5 and human induced pluripotent stem cell-derived myotubes (hiPSCM). Ile reverses hyperammonemia-induced reduction in the maximum respiratory capacity, complex I, II, and III functions in early passage murine myotubes and hiPSCM. Consistently, low ATP content and impaired global protein synthesis (high energy requiring cellular process) during hyperammonemia are reversed by Ile in murine myotubes and hiPSCM. Lower abundance of critical regulators of protein synthesis in mTORC1 signaling, and increased phosphorylation of eukaryotic initiation factor 2α are also reversed by Ile. Genetic depletion studies showed that Ile responses are independent of the amino acid transporter LAT1/SLC7A5. Our studies show that Ile reverses the hyperammonemia-induced impaired mitochondrial oxidative function, cataplerosis, and SAMP in a LAT1/SLC7A5 transporter-independent manner.

Keywords: L-isoleucine; anaplerosis; cataplerosis; hyperammonemia; mitochondrial oxidation; myotube.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acids, Branched-Chain / metabolism
  • Ammonia / metabolism
  • Animals
  • Humans
  • Hyperammonemia* / drug therapy
  • Hyperammonemia* / metabolism
  • Induced Pluripotent Stem Cells* / metabolism
  • Isoleucine
  • Large Neutral Amino Acid-Transporter 1
  • Mice
  • Mitochondrial Diseases*
  • Muscle Fibers, Skeletal / metabolism

Substances

  • Amino Acids, Branched-Chain
  • Ammonia
  • Isoleucine
  • Large Neutral Amino Acid-Transporter 1